NCT04514627 Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 Status COMPLETED Phase NA
NCT04514302 Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19 Status COMPLETED Phase PHASE1
NCT04512027 Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. Status COMPLETED Phase NA
NCT04511650 Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 Status TERMINATED Phase PHASE2
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above Status COMPLETED Phase PHASE3
NCT04510012 Characterizing the Immune Response and Neuronal Damage in COVID-19 Status COMPLETED Phase N/A
NCT04509999 Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection Status WITHDRAWN Phase PHASE3
NCT04507256 AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 Status COMPLETED Phase PHASE1